BML Capital Management’s LAVA Therapeutics LVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.6M	Buy	1,970,610 +10,000	+0.5%	+$13.2K	1.97%	12
2025 Q1	$2.49M	Buy	+1,960,610	New	+$2.49M	2.02%	12